Papers
1
Total Citations
15
H-Index
1
About
B Fellman is a leading clinical researcher in gynecologic oncology, with a primary focus on advancing surgical approaches for early-stage cervical cancer. Their most notable contribution is the seminal work on the "23 Concerv" prospective trial, which evaluated conservative surgery for low-risk early stage cervical cancer. This 2019 study, with 15 citations, has been instrumental in shaping less radical, fertility-sparing treatment protocols, reducing morbidity while maintaining oncologic safety. Fellman's research bridges the gap between aggressive traditional surgery and patient-centered care, emphasizing the importance of tailoring interventions to tumor biology and patient age. Their work has influenced international guidelines and inspired further trials on minimally invasive techniques. Beyond this landmark study, Fellman has contributed to the broader discourse on surgical de-escalation, earning recognition for their methodical trial design and commitment to evidence-based practice. For students and researchers, Fellman exemplifies how a single, well-executed clinical trial can redefine standards of care, making their biography a testament to the power of focused, impactful research in oncology.
Research Focus
Key Achievements
Top Papers
- 1